-
Nov 29, 2018
F-star Wins “Best Partnership Alliance” Award at the 14th Annual Scrip Awards Ceremony -
Nov 01, 2018
F-star to Disclose Targets and Preclinical Data on New Agonist Bispecific Antibody Programmes -
Oct 15, 2018
F-star Appoints Dr Eliot Forster as Chief Executive Officer -
Sep 10, 2018
F-star Appoints Nessan Bermingham as Chairman of its Board of Directors -
Jul 24, 2018
F-star Announces the Achievement of a Clinical Milestone in its Immuno-Oncology Collaboration with Merck -
May 30, 2018
F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma -
May 21, 2018
F-star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody -
Apr 09, 2018
F-star to Present New Preclinical Data on FS118, a First-in-Class Immuno-Oncology Bispecific Antibody, at the AACR 2018 Annual Meeting -
Jan 09, 2018
F-star Provides an Update on its Collaboration with Denali Therapeutics -
Sep 22, 2017
F-star Recognised as a Finalist in Two Categories of the Scrip Awards 2017
Pagination
